Former Pfizer R&D chief Mikael Dolsten joins Immunai’s board of directorsDolsten brings decades of pharmaceutical leadership to advance AI-driven drug discovery.Tel Aviv startup Immunai aim to map the immune system(photo credit: Courtesy)
